Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Lnc056 helps hair follicle stem cells grow by increasing TRIP6 expression.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Improved CRBN ligands make protein degraders more effective and drug-like.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Activating GLI1 signaling without primary cilia could be a promising treatment for neuroblastoma.

A low dose of rapamycin increases inner ear hair cell creation by boosting SOX2+ cell numbers.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

The IRF2BP2 gene affects sheep fleece quality by influencing fiber traits.

Loricrin affects skin immune function and homeostasis.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

XEDAR triggers a specific signaling pathway in cells.

The study found potential new DNA patterns in fertility genes, but further testing is needed.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ocu-miR-205 affects hair density in Rex rabbits by promoting cell changes and influencing hair follicle phases.

Ritlecitinib is safe for treating alopecia areata for up to 48 weeks.

CTIP2 may help in skin development and maintenance.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.